What is Grappa?
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) is a nonprofit entity dedicated to advancing the understanding and treatment of psoriatic diseases. It serves as a crucial hub for collaboration among rheumatologists, dermatologists, and other healthcare professionals, fostering research, education, and networking opportunities. GRAPPA's work is vital for improving diagnostic and therapeutic strategies globally for individuals affected by psoriasis and psoriatic arthritis.
How much funding has Grappa raised?
Grappa has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Grappa?
The substantial capital infusion, characterized as large-scale late-stage funding and a major strategic investment, positions Grappa for significant expansion and enhanced operational capacity. This financial momentum is expected to accelerate research initiatives, broaden educational outreach, and strengthen collaborative efforts within the psoriatic disease community, further solidifying its leadership in the sector.
See full Grappa company page